BioCentury
ARTICLE | Clinical News

Axanum aspirin/esomeprazole magnesium regulatory update

June 7, 2010 7:00 AM UTC

AstraZeneca submitted an MAA in Europe for Axanum aspirin/esomeprazole to prevent cardiovascular and cerebrovascular events in patients requiring continuous low-dose aspirin treatment who are at risk ...